07
May
Share price moved up by 4700 from its previous close of Rs 000. Live share price historical charts volume market capitalisation market performance reports and other company details.
4575 764 per Ranbaxy sharea premium of 18 above the companys 30-dayweighted average share price and 243.
Ranbaxy share price india. Ranbaxy Laboratories Limited Share Price Today Live NSE Stock Price. Get the latest Ranbaxy Laboratories Limited news company updates quotes offers annual financial reports graph volumes 52 week high low buy sell tips balance sheet historical charts market performance capitalisation dividends volume profit and loss account research results and more details at NSE India. Ranbaxy Labs Share Price Ranbaxy Labs Stock Price Ranbaxy Laboratories Ltd.
Stock Price Share Price Live BSENSE Ranbaxy Laboratories. Ranbaxy Laboratories Ltd Live BSE Share Price today Ranbaxy Lab latest news 500359 announcements. Ranbaxy Lab financial results Ranbaxy Lab shareholding Ranbaxy Lab annual reports Ranbaxy Lab pledge Ranbaxy Lab insider trading and compare with peer companies.
Ranbaxy Laboratories Ltd. Share price moved up by 4700 from its previous close of Rs 000. 31 rows Price trends tend to persist so its worth looking at them when it comes to a.
- Ranbaxy Laboratories promoter Parvinder Singh has sold around 20 lakh equity shares of the company at a price of Rs650 per share. Over a dozen foreign institutional investors FIIs have picked up these shares in a deal struck by JM Financial and Morgan Stanley. Sun Pharma is ranked number 2 in terms of Exploitation in terms of bad culture no work life balance as per the survey done for India and further it received same results in the internal anonymous feedback.
Current Share price of Sun pharma is NSE. On March 12 2009 Ranbaxys share price hit Rs 134 the lowest in its history. By June that year it had been evicted from the 30-stock Sensex.
Then in 2011 calendar year the company posted a mammoth loss of Rs 2883 crore and its new owners slashed its net income by 63 to. Sun Pharma is the No. 1 and largest pharmaceutical company in India with over 8 market share in the domestic market AIOCD AWACS for 12 months ending June 2020.
The company has been ranked No. 1 with over 11 different classes of doctors SMSRC Prescription Data. Get Live BSE NSE stock price of Ranbaxy Laboratories Ltd- Amalgamation with historical charts financial reports volume market performance latest news on NDTV Profit.
Get Ranbaxy Laboratories Ltd. Live share price historical charts volume market capitalisation market performance reports and other company details. That July move by the US authorities and other news that followed sent Ranbaxy shares tumbling to a low of Rs 16945 in four months flat.
Its todays share price is 8599. Its current market capitalisation stands at Rs 366028 Cr. In the latest quarter company has reported Gross Sales of Rs.
6908957 Cr and Total Income of Rs76497. Ranbaxy shareholders will receive 08 shares of Sun Pharma for each share of Ranbaxy with an implied value of 457 rupees a premium of 18 percent to. The deal32 billion in equity 800 million in debtwas valued at Rs.
4575 764 per Ranbaxy sharea premium of 18 above the companys 30-dayweighted average share price and 243. Ranbaxy Laboratories Ltd share price today - on 11 August 2021. Share price target by A1 Intraday Tips.
Chart and Current price for Ranbaxy Laboratories Ltd. Under these agreements Ranbaxy shareholders will receive 08 share of Sun Pharma for each share of Ranbaxy. This exchange ratio represents an implied value of Rs 457 for each Ranbaxy share a premium of 18 to Ranbaxyâs 30-day volume-weighted average share price and a premium of 243 to Ranbaxyâs 60-day volume-weighted average.
The share price of Ranbaxy rose 386 percent to Rs 52640 BSE Japanese and Rs 52585 NSE on June 9 two days before the company announced its buyout by acquisition in Daiichi Sankyo Table IV. Indiaa benchmark index Sensex plunged 506 points the same day. This exchange ratio represents an implied value of Rs 457 for each share of Ranbaxy a premium of 18 to Ranbaxys 30-day volume-weighted average share price and a premium of 243 to Ranbaxys 60-day volume-weighted average share price in each case as of the close of business on April 4 2014.
Daiichi offered a share price of INR 737 with a transaction value of around 46 billion valuing Ranbaxy at 85 billion. Daiichi ended up acquiring 6392 shares of Ranbaxy by Nov 2008. Including transaction costs the deal costs Daiichi 498 billion and they recorded goodwill of 417billion.
Ranbaxy Laboratories Limited was an Indian pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.
In 2008 Japanese pharmaceutical company Daiichi Sankyo acquired a controlling share in Ranbaxy and in 2014 Sun Pharma acquired 100 of Ranbaxy in an all.